Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnab Das

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Ophthalmology and Therapy|January 25, 2022
Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective StudyDebdulal Chakraborty, Sabyasachi Sengupta, Soumen Mondal, et al.
Indian Journal of Ophthalmology|April 16, 2024
Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in IndiaDebdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 15, 2021
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE StudyDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Applied Optics|August 12, 2025
Lateral shearing common-path digital holographic microscopy with iterative reconstructionHarshal Chaudhari, Arnab Das, Harsh Vikram Singh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 1, 2024
Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational StudyDebdulal Chakraborty, Subhendu Boral, Tushar Kanti Sinha, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 17, 2023
Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World EvidenceDebdulal Chakraborty, Soumen Mondal, Subhendu Boral, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 2, 2024
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational StudyDebdulal Chakraborty, Tushar Kanti Sinha, Aniruddha Maiti, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2022
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two-Week OutcomesDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Ophthalmology and Therapy|April 17, 2021
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal DiseasesDebdulal Chakraborty, Michael W Stewart, Jay U Sheth, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
The 2'-endo conformation of arabinose-CTP and arabinose-UTP inhibit viral polymerases by inducing long pausesZiyang Xiao, Arnab Das, Abha Jain, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Ophthalmology and Therapy|January 25, 2022
Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective StudyDebdulal Chakraborty, Sabyasachi Sengupta, Soumen Mondal, et al.
Indian Journal of Ophthalmology|April 16, 2024
Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in IndiaDebdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 15, 2021
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE StudyDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Applied Optics|August 12, 2025
Lateral shearing common-path digital holographic microscopy with iterative reconstructionHarshal Chaudhari, Arnab Das, Harsh Vikram Singh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 1, 2024
Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational StudyDebdulal Chakraborty, Subhendu Boral, Tushar Kanti Sinha, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 17, 2023
Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World EvidenceDebdulal Chakraborty, Soumen Mondal, Subhendu Boral, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 2, 2024
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational StudyDebdulal Chakraborty, Tushar Kanti Sinha, Aniruddha Maiti, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2022
Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two-Week OutcomesDebdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, et al.
Ophthalmology and Therapy|April 17, 2021
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal DiseasesDebdulal Chakraborty, Michael W Stewart, Jay U Sheth, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
The 2'-endo conformation of arabinose-CTP and arabinose-UTP inhibit viral polymerases by inducing long pausesZiyang Xiao, Arnab Das, Abha Jain, et al.
Pageof 8